AMILO-LATAM
@AmiloLATAM
Followers
256
Following
384
Media
143
Statuses
616
Grupo Latinoamericano de Investigación en Amiloidosis Cardiaca// Latin American Research Group on Cardiac Amyloidosis. Contact: [email protected]
Latinoamerica
Joined February 2022
Participando en #CongresoSIAC #SIAC2024 #SIAC24 mostrando parte de nuestro trabajo de Investigación del Gpo #AmiloLATAM @SIAC_cardio
0
0
4
RT @Amyloidosis_ARC: Many #amyloidosis patients face not only a devastating disease but also delayed or missed diagnoses. With treatments a….
0
5
0
RT @ctinocomesquita: 🚨 New Publication! 🚨.Our team at @UFF_oficial, with @almallahmo , just published a systematic review and meta-analysis….
0
9
0
RT @JNCjournal: Left ventricular myocardium-to-blood ratio >1.5 on 99mTc-HMDP SPECT/CT accurately detects ATTR-CM @helsinkiuni #cvnuc #amy….
0
9
0
RT @JNCjournal: Is bone avid tracer cardiac scintigraphy always the preferred approach to screen at risk populations for TTR cardiac amyloi….
journalofnuclearcardiology.org
We have witnessed tremendous progress over the last decade in systemic amyloidosis. For transthyretin amyloidosis (ATTR), there are now two therapeutic approaches, including TTR stabilizers and TTR...
0
12
0
RT @Amyloidosis_ARC: New in JAHA: ASPIRE + expert collaborators outline how #AI could help detect #CardiacAmyloidosis earlier. Strong scien….
0
5
0
RT @AmyloidosisA: 👩🔬 Meet the brilliant minds behind #ATTRCongress 2025!.💡 The Scientific Committee is crafting a powerful program to adva….
0
4
0
RT @StanfordDeptMed: New research featuring #StanDOM's @graciafahed, @KMAlexanderMD, @Ron_Witteles, Francois Haddad & Gabriela Spencer-Boni….
0
3
0
RT @AmyloidosisA: Q: How is wild-type ATTR amyloidosis different from hereditary?.A: It’s not inherited, but age-related. The unstable TTR….
0
4
0
RT @AmyloidosisA: 🫀 We’re heading to #HeartFailure2025 in Belgrade & online, May 17–20!.🌍 The top global event on heart failure—incl. a foc….
0
2
0
RT @JACCJournals: In this #JACCCardioOnc review, Dr. @DavidGGent, et al provide an overview of cardiotoxicity after hematopoietic cell tran….
0
4
0
RT @JACCJournals: Establishing repeatability, reproducibility, & accuracy of imaging metrics is paramount for use in pivotal multicenter #a….
0
9
0
RT @JLRosenthal: Please share this exciting and interactive Amyloid case based seminar w/your fellow Amyloid champions and trainees. @Bre….
0
13
0
RT @Cornerstone_CME: IT'S TIME! The 2nd Annual #ATTR Early-Career Research Forum abstract submission window is open!. Submit here for a cha….
0
7
0
RT @AmyloidosisA: 🇮🇹 The 5th International ATTR #Amyloidosis Meeting is coming on 📅 September 25-26, 2025, in 📍Baveno, Italy!. This must-at….
0
4
0
RT @ISA_Amyloidosis: Amyloidosis Mysteries: Cracking the Toughest Cases 📅 Tuesday, May 13, 2025 12:00 PM EDT.Join us for an engaging onlin….
0
9
0
RT @aVoice4ALS: @graciafahed @JACCJournals @KMAlexanderMD @Ron_Witteles Thanks @graciafahed & @Ron_Witteles for covering these racial gaps….
0
2
0
RT @Amyloidosis_ARC: 📢 [New Publication] Evaluating the validity, reliability, and structure of our #ATTR #QOL patient-reported outcome mea….
jpro.springeropen.com
Background The diversity of disease phenotypes associated with transthyretin (ATTR) amyloidosis poses challenges for measurement of health outcomes. The Transthyretin Amyloidosis – Quality of Life...
0
4
0
RT @graciafahed: 🫀Therapeutic options for ATTR-CM are expanding rapidly, yet diagnostic delays remain significant.👇Our latest @JACCJournals….
0
7
0
RT @DorbalaSharmila: Highly recommend this practical PET workshop for all nuclear cardiologists planning for PET MPI programs. Especially r….
0
3
0